A detailed history of Bigelow Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Bigelow Investment Advisors, LLC holds 2,005 shares of NVO stock, worth $230,735. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,005
Previous 2,005 -0.0%
Holding current value
$230,735
Previous $257,000 11.28%
% of portfolio
0.14%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$102.11 - $135.92 $204,730 - $272,519
2,005 New
2,005 $257,000
Q4 2022

Jan 26, 2023

BUY
$102.55 - $135.33 $153,825 - $202,995
1,500 New
1,500 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bigelow Investment Advisors, LLC Portfolio

Follow Bigelow Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bigelow Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bigelow Investment Advisors, LLC with notifications on news.